Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture-Reference-Cited by-同舟云学术

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

Published:2021-05 Issue:7 Volume:35 Page:109133
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Bafna Khushboo,White Kris,Harish Balasubramanian,Rosales Romel^ORCID,Ramelot Theresa A.,Acton Thomas B.,Moreno Elena,Kehrer Thomas,Miorin Lisa,Royer Catherine A.,García-Sastre Adolfo,Krug Robert M.^ORCID,Montelione Gaetano T.^ORCID

Funder

Icahn School of Medicine at Mount Sinai

Rensselaer Polytechnic Institute

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening;Amanat;Curr. Protoc. Microbiol.,2020

2. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain;Anand;EMBO J.,2002

3. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles;Angelini;MBio,2013

4. X-ray structure of SARS-CoV-2 main protease bound to boceprevir at 1.45 A. PDB ID 6WNP;Anson,2020

5. Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs;Anson,2020

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. Structural Basis of Main Proteases of Coronavirus Bound to Bofutrelvir;Journal of Molecular Biology;2024-11

3. Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication;DARU Journal of Pharmaceutical Sciences;2024-07-19

4. Therapeutic cysteine protease inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-02

5. After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives;International Journal of Molecular Sciences;2024-01-06